Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIC in Ragweed-Allergic Adults
NCT00346086Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- May 2001
- Primary completion
- Aug 2001
- Modality
- Antisense DNA, Prophylactic Vaccines, Small Interfering RNA (siRNA)
- Countries
- 1
01
Overview
A Phase 2 trial of amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate in seasonal allergic rhinitis (SAR), sponsored by Johns Hopkins University. Started May 2001; status: completed.
02
Drugs
amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00346086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00346086.